Masa-Jiménez Juan F, Ramírez-Molina Victor R, De Dios-Calama Celia
Emeritus Pulmonologist in San Pedro de Alcántara Hospital, Cáceres, Spain.
Academic Numerary of the Royal Academy of Medicine in Salamanca University, Salamanca, Spain.
Semin Respir Crit Care Med. 2025 May 29. doi: 10.1055/a-2591-5583.
Obesity hypoventilation syndrome (OHS) is defined by the combination of obesity (body mass index [BMI] ≥30 kg/m), sleep-disordered breathing, and daytime hypercapnia (arterial carbon dioxide tension [PaCO] ≥45 mm Hg at sea level) during wakefulness occurring in the absence of an alternative neuromuscular, mechanical, or metabolic explanation for hypoventilation. Patients with OHS can be classified by phenotypes depending on whether or not they have obstructive respiratory events: hypoventilation and no or not significant obstructive sleep apnea (OSA) and hypoventilation and significant OSA; we also add a third phenotype, which is the hospitalized patient with acute-on-chronic respiratory failure. We describe the mid- and long-term outcomes with and without positive airway pressure (PAP) by these three phenotypes.
肥胖低通气综合征(OHS)的定义为肥胖(体重指数[BMI]≥30kg/m²)、睡眠呼吸紊乱以及清醒时日间高碳酸血症(海平面时动脉二氧化碳分压[PaCO₂]≥45mmHg)同时存在,且不存在导致通气不足的其他神经肌肉、机械或代谢方面的原因。OHS患者可根据是否存在阻塞性呼吸事件分为不同表型:通气不足且无或无显著阻塞性睡眠呼吸暂停(OSA)以及通气不足且有显著OSA;我们还增加了第三种表型,即患有急性慢性呼吸衰竭的住院患者。我们描述了这三种表型在接受和未接受气道正压通气(PAP)治疗情况下的中长期预后。